1
|
Mu Y, Li M, Zhao X, Gong C, Luo Z, Li B, Zhang W, Ge X, Chen S, Zhou J. TiO 2 Nanotube Implants Modified with Silk Fibroin and Mesoporous Silica Nanocomposite Coatings Enable Efficient Drug Release to Promote Osteogenesis. ACS APPLIED MATERIALS & INTERFACES 2025; 17:30600-30612. [PMID: 40289330 PMCID: PMC12123568 DOI: 10.1021/acsami.5c03599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/20/2025] [Revised: 04/16/2025] [Accepted: 04/20/2025] [Indexed: 04/30/2025]
Abstract
Enhanced bone healing within 1 week after post-titanium (Ti) dental implant surgery especially contributes to the subsequent long-term osseointegration, and the commonly used drug-loaded TiO2 nanotubes (TNTs) can promote osteogenesis yet still face the challenge of burst drug release that makes it difficult to maintain long-term effective drug concentrations and good osseointegration. Here, we prepared a double drug loading/release system of silk fibroin/mesoporous silica nanoparticles (SF/MSN) nanocomposite coating modified TNTs (TAMA) with AZD2858 (Wnt/β-catenin pathway agonist for promoting osteogenesis) as the therapeutic drug, realizing a long-term stable drug release and better osteogenesis. The increased β-sheet content of SF reduced the degradation rate of the SF/MSN coating, thus avoiding the AZD2858 burst release. The adsorption of MSN maintained the effective drug concentration more than 1 week that was especially critical for early bone healing. Under the protection of SF/MSN coating, the TAMA implant showed a well-organized spatial release of AZD2858, well enabling the osteogenic differentiation and mineralization at cellular level for up to 21 days. Animal experiments further demonstrated that the slow release of AZD2858 in the TAMA implant effectively activated the Wnt/β-catenin pathway, enabling rapid bone healing in the early stage of implantation and finally achieving the best osseointegration efficacy. Thus, this study proposed an efficient strategy for developing high-performance dental implants via the construction of a biodegradable SF/MSN coating.
Collapse
Affiliation(s)
- Yanting Mu
- Beijing
Key Laboratory of Tooth Regeneration and Function Reconstruction,
Beijing Stomatological Hospital, Capital
Medical University, Beijing, 100071, China
| | - Ming Li
- China-America
Institute of Neuroscience and Beijing Institute of Geriatrics, Xuanwu
Hospital, Capital Medical University, Beijing, 100053, China
| | - Xiang Zhao
- Beijing
Key Laboratory of Tooth Regeneration and Function Reconstruction,
Beijing Stomatological Hospital, Capital
Medical University, Beijing, 100071, China
- Beijing
Institute of Brain Disorders, Capital Medical
University, Beijing, 100069, China
- Shanxi
Medical University School and Hospital of Stomatology, Taiyuan, 030001, China
| | - Chaihong Gong
- Beijing
Institute of Brain Disorders, Capital Medical
University, Beijing, 100069, China
- School
of Life Science, Key Laboratory of Optoelectronic Chemical Materials
and Devices of Ministry of Education, Jianghan
University, Wuhan, 430056, China
| | - Zhang Luo
- Beijing
Institute of Brain Disorders, Capital Medical
University, Beijing, 100069, China
- School
of Life Science, Key Laboratory of Optoelectronic Chemical Materials
and Devices of Ministry of Education, Jianghan
University, Wuhan, 430056, China
| | - Bing Li
- Shanxi
Medical University School and Hospital of Stomatology, Taiyuan, 030001, China
| | - Weiying Zhang
- School
of Life Science, Key Laboratory of Optoelectronic Chemical Materials
and Devices of Ministry of Education, Jianghan
University, Wuhan, 430056, China
| | - Xiaoxiao Ge
- Beijing
Institute of Brain Disorders, Capital Medical
University, Beijing, 100069, China
| | - Su Chen
- Beijing
Key Laboratory of Tooth Regeneration and Function Reconstruction,
Beijing Stomatological Hospital, Capital
Medical University, Beijing, 100071, China
| | - Jian Zhou
- Beijing
Key Laboratory of Tooth Regeneration and Function Reconstruction,
Beijing Stomatological Hospital, Capital
Medical University, Beijing, 100071, China
- Beijing
Laboratory
of Oral Health, Capital Medical University, Beijing, 100069, China
- Laboratory
for Oral and General Health Integration and Translation, Beijing Tiantan
Hospital, Capital Medical University, Beijing, 100070, China
| |
Collapse
|
2
|
Zhang Y, Jiang M, Wei M, Wu C, Huang Y, Song B, Xu Y, Zhang H, Shen Y, Wu D, Zheng Y, Li M, Ji X. MgSO 4 as a novel hypothermia infusion solution promotes ischemic stroke recovery through Ca 2+ regulation of neurovascular units. Theranostics 2025; 15:1896-1913. [PMID: 39897562 PMCID: PMC11780535 DOI: 10.7150/thno.104879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2024] [Accepted: 12/18/2024] [Indexed: 02/04/2025] Open
Abstract
The neuroprotection of acute ischemic stroke (AIS) patients to alleviate the reperfusion injury is a long-standing problem. Although the intra-arterial selective cooling saline infusion (IA-SCSI) is a promising technique to improve the outcome of AIS, the clinical results are not sufficiently satisfactory. Magnesium-containing solutions such as magnesium sulfate (MgSO4) can protect cells by modulating the intracellular Ca2+ content in damaged cells, suggesting that they could be hypothermia infusion solution. In this study, we hypothesized that MgSO4, as a novel hypothermia infusion solution (IA-SCMI), can promote AIS recovery. Methods: First, IA-SCMI was performed in rats subjected to the middle cerebral artery occlusion. The effect of combined hypothermia and MgSO4 treatment on different neurovascular (NVU) cells after oxygen-glucose deprivation/reoxygenation (OGD/R) injury was examined. Results: Compared with the IA-SCSI or IA-MgSO4 infusion alone, IA-SCMI offered the best protective effect by improving neurological defects, and alleviating brain integrity damage and CBF reduction. Meanwhile, in vitro results revealed that the combination of hypothermia and MgSO4 provided maximum protection to the NVU cells, and this protective effect was mainly achieved through the regulation of Ca2+ homeostasis in different cells. Conclusion: MgSO4 may be a promising hypothermia infusion solution to facilitate the recovery of neurological function in AIS patients.
Collapse
Affiliation(s)
- Yang Zhang
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China
- China-America Institute of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Miaowen Jiang
- Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China
| | - Ming Wei
- Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China
| | - Chuanjie Wu
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China
- China-America Institute of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Yiming Huang
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China
- China-America Institute of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Baoying Song
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China
- China-America Institute of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Yi Xu
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China
- China-America Institute of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Hongkang Zhang
- School of Materials Science and Engineering, Peking University; Beijing, China
| | - Yunong Shen
- School of Materials Science and Engineering, Peking University; Beijing, China
| | - Di Wu
- China-America Institute of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Yufeng Zheng
- School of Materials Science and Engineering, Peking University; Beijing, China
| | - Ming Li
- China-America Institute of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Xunming Ji
- China-America Institute of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China
- Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China
- Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China
| |
Collapse
|
3
|
Zhang Y, Jiang M, Baoying S, Gao Y, Xu Y, Qi Z, Wu D, Li M, Ji X. Trends and hotspots of the neuroprotection of hypothermia treatment: A bibliometric and visualized analysis of research from 1992 to 2023. CNS Neurosci Ther 2024; 30:e14795. [PMID: 38867401 PMCID: PMC11168963 DOI: 10.1111/cns.14795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2023] [Revised: 05/02/2024] [Accepted: 05/23/2024] [Indexed: 06/14/2024] Open
Abstract
AIM Recent studies have extensively investigated hypothermia as a therapeutic approach for mitigating neural damage. Despite this, bibliometric analyses specifically focusing on this area remain scarce. Consequently, this study aims to comprehensively outline the historical framework of research and to pinpoint future research directions and trends. METHODS Articles spanning from 2003 to 2023, relevant to both "neuroprotection" and "hypothermia", were sourced from the Web of Science Core Collection. The CiteSpace software facilitated a comprehensive evaluation and analysis of these publications. This analysis included examining the annual productivity, collaboration among nations, institutions, and authors, as well as the network of co-cited references, authors and journals, and the co-occurrence of keywords, and their respective clusters and trends, all of which were visualized. RESULTS This study included 2103 articles on the neuroprotection effects of hypothermia, noting a consistent increase in publications since 1992. The United States, the University of California System, and Ji Xunming emerged as the most productive nation, institution, and author, respectively. Analysis of the top 10 co-cited publications revealed that seven articles focused on the effects of hypothermia in infants with hypoxic-ischemic encephalopathy, while three studies addressed cardiac arrest. Shankaran S and the journal Stroke were the most frequently co-cited author and journal, respectively. Keyword cluster analysis identified ischemic stroke as the primary focus of hypothermia therapy historically, with cardiac arrest and neonatal hypoxic-ischemic encephalopathy emerging as current research foci. CONCLUSIONS Recent studies on the neuroprotective effects of hypothermia in cardiac arrest and neonatal hypoxic-ischemic encephalopathy suggest that hypothermia may mitigate neural damage associated with these conditions. However, the application of hypothermia in the treatment of ischemic stroke remains confined to animal models and in vitro studies, with a notable absence of evidence from multicenter randomized controlled trials (RCTs). Further research is required to address this gap.
Collapse
Affiliation(s)
- Yang Zhang
- Department of NeurologyXuanwu Hospital, Capital Medical UniversityBeijingChina
- China‐America Institute of Neurology, Xuanwu Hospital, Capital Medical UniversityBeijingChina
| | - Miaowen Jiang
- Beijing Institute for Brain Disorders, Capital Medical UniversityBeijingChina
| | - Song Baoying
- Department of NeurologyXuanwu Hospital, Capital Medical UniversityBeijingChina
- China‐America Institute of Neurology, Xuanwu Hospital, Capital Medical UniversityBeijingChina
| | - Yuan Gao
- School of Instrumentation and Optoelectronic Engineering, Beihang UniversityBeijingChina
| | - Yi Xu
- Department of NeurologyXuanwu Hospital, Capital Medical UniversityBeijingChina
- China‐America Institute of Neurology, Xuanwu Hospital, Capital Medical UniversityBeijingChina
| | - Zhengfei Qi
- Beijing Institute for Brain Disorders, Capital Medical UniversityBeijingChina
| | - Di Wu
- China‐America Institute of Neurology, Xuanwu Hospital, Capital Medical UniversityBeijingChina
| | - Ming Li
- China‐America Institute of Neurology, Xuanwu Hospital, Capital Medical UniversityBeijingChina
| | - Xunming Ji
- China‐America Institute of Neurology, Xuanwu Hospital, Capital Medical UniversityBeijingChina
- Beijing Institute for Brain Disorders, Capital Medical UniversityBeijingChina
- Department of NeurosurgeryXuanwu Hospital, Capital Medical UniversityBeijingChina
| |
Collapse
|
4
|
Liu M, Sun Y, Teh DBL, Zhang Y, Cao D, Mei Q. Nanothermometry for cellular temperature monitoring and disease diagnostics. INTERDISCIPLINARY MEDICINE 2024; 2. [DOI: 10.1002/inmd.20230059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/02/2023] [Accepted: 02/17/2024] [Indexed: 01/05/2025]
Abstract
AbstractBody temperature variations, including the generation, transfer, and dissipation of heat, play an important role throughout life and participate in all biological events. Cellular temperature information is an indispensable link in the comprehensive understanding of life science processes, but traditional testing strategies cannot provide sufficient information due to their low precision and inefficient cellular‐entrance. In recent years, with the help of luminescent nanomaterials, a variety of new thermometers have been developed to achieve real‐time temperature measurement at the micro/nano scale. In this review, we summarized the latest advances in several nanoparticles for cellular temperature detection and their related applications in revealing cell metabolism and disease diagnosis. Furthermore, this review proposed a few challenges for the nano‐thermometry, expecting to spark novel thought to push forward its preclinical and translational uses.
Collapse
Affiliation(s)
- Meilin Liu
- Department of Medical Biochemistry and Molecular Biology School of Medicine Jinan University Guangzhou China
| | - Yaru Sun
- Department of Medical Biochemistry and Molecular Biology School of Medicine Jinan University Guangzhou China
| | - Daniel Boon Loong Teh
- Departments of Ophthalmology Anatomy Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore
| | - Yi Zhang
- Department of Medical Biochemistry and Molecular Biology School of Medicine Jinan University Guangzhou China
| | - Donglin Cao
- The Affiliated Guangdong Second Provincial General Hospital of Jinan University Guangzhou China
- Department of Laboratory Medicine Guangdong Second Provincial General Hospital Guangzhou China
| | - Qingsong Mei
- Department of Medical Biochemistry and Molecular Biology School of Medicine Jinan University Guangzhou China
| |
Collapse
|
5
|
Zhang M, An H, Gu Z, Zhang YC, Wan T, Jiang HR, Zhang FS, Jiang BG, Han N, Wen YQ, Zhang PX. Multifunctional wet-adhesive chitosan/acrylic conduit for sutureless repair of peripheral nerve injuries. Int J Biol Macromol 2023; 253:126793. [PMID: 37709238 DOI: 10.1016/j.ijbiomac.2023.126793] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2023] [Revised: 08/30/2023] [Accepted: 09/05/2023] [Indexed: 09/16/2023]
Abstract
The incidence of peripheral nerve injury (PNI) is high worldwide, and a poor prognosis is common. Surgical closure and repair of the affected area are crucial to ensure the effective treatment of peripheral nerve injuries. Despite being the standard treatment approach, reliance on sutures to seal the severed nerve ends introduces several limitations and restrictions. This technique is intricate and time-consuming, and the application of threading and punctate sutures may lead to tissue damage and heightened tension concentrations, thus increasing the risk of fixation failure and local inflammation. This study aimed to develop easily implantable chitosan-based peripheral nerve repair conduits that combine acrylic acid and cleavable N-hydroxysuccinimide to reduce nerve damage during repair. In ex vivo tissue adhesion tests, the conduit achieved maximal interfacial toughness of 705 J m-2 ± 30 J m-2, allowing continuous bridging of the severed nerve ends. Adhesive repair significantly reduces local inflammation caused by conventional sutures, and the positive charge of chitosan disrupts the bacterial cell wall and reduces implant-related infections. This promises to open new avenues for sutureless nerve repair and reliable medical implants.
Collapse
Affiliation(s)
- Meng Zhang
- Department of Orthopedics and Trauma, Peking University People's Hospital, Key Laboratory of Trauma and Neural Regeneration, Peking University, National Center for Trauma Medicine, Beijing 100044, China.
| | - Heng An
- Beijing Key Laboratory for Bioengineering and Sensing Technology, Daxing Research Institute, School of Chemistry & Biological Engineering, University of Science & Technology Beijing, Beijing 100083, China.
| | - Zhen Gu
- Beijing Key Laboratory for Bioengineering and Sensing Technology, Daxing Research Institute, School of Chemistry & Biological Engineering, University of Science & Technology Beijing, Beijing 100083, China.
| | - Yi-Chong Zhang
- Department of Orthopedics and Trauma, Peking University People's Hospital, Key Laboratory of Trauma and Neural Regeneration, Peking University, National Center for Trauma Medicine, Beijing 100044, China.
| | - Teng Wan
- Department of Orthopedics and Trauma, Peking University People's Hospital, Key Laboratory of Trauma and Neural Regeneration, Peking University, National Center for Trauma Medicine, Beijing 100044, China.
| | - Hao-Ran Jiang
- Department of Orthopedics and Trauma, Peking University People's Hospital, Key Laboratory of Trauma and Neural Regeneration, Peking University, National Center for Trauma Medicine, Beijing 100044, China.
| | - Feng-Shi Zhang
- Department of Orthopedics and Trauma, Peking University People's Hospital, Key Laboratory of Trauma and Neural Regeneration, Peking University, National Center for Trauma Medicine, Beijing 100044, China.
| | - Bao-Guo Jiang
- Department of Orthopedics and Trauma, Peking University People's Hospital, Key Laboratory of Trauma and Neural Regeneration, Peking University, National Center for Trauma Medicine, Beijing 100044, China.
| | - Na Han
- Department of Orthopedics and Trauma, Peking University People's Hospital, Key Laboratory of Trauma and Neural Regeneration, Peking University, National Center for Trauma Medicine, Beijing 100044, China.
| | - Yong-Qiang Wen
- Beijing Key Laboratory for Bioengineering and Sensing Technology, Daxing Research Institute, School of Chemistry & Biological Engineering, University of Science & Technology Beijing, Beijing 100083, China.
| | - Pei-Xun Zhang
- Department of Orthopedics and Trauma, Peking University People's Hospital, Key Laboratory of Trauma and Neural Regeneration, Peking University, National Center for Trauma Medicine, Beijing 100044, China.
| |
Collapse
|